thromboxanes has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amtul, Z; Beyreuther, K; Rozmahel, RF; Uhrig, M; Wang, L | 1 |
| Gertz, BJ; Reicin, A; Sperling, RS; Weir, MR | 1 |
1 review(s) available for thromboxanes and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Blood Pressure; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Epoprostenol; Humans; Isoenzymes; Lactones; Membrane Proteins; Models, Animal; Naproxen; Osteoarthritis; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Sulfones; Thrombosis; Thromboxanes | 2003 |
1 other study(ies) available for thromboxanes and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Detrimental effects of arachidonic acid and its metabolites in cellular and mouse models of Alzheimer's disease: structural insight.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Arachidonic Acid; Biosynthetic Pathways; Biotinylation; Cannabinoid Receptor Modulators; Chlorocebus aethiops; COS Cells; Cricetinae; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Immunoprecipitation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Peptide Fragments; Plaque, Amyloid; Prostaglandins; Thromboxanes; Transfection | 2012 |